Evolution of heart disease in utero

Related Experiment Video

Updated: Aug 22, 2026

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography
08:01

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Published on: November 22, 2013

J Trines1, L K Hornberger

  • 1Fetal Cardiac Program, Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto.

Pediatric Cardiology
|September 14, 2004
PubMed

Insights

Fetal heart development involves critical early stages, but cardiovascular defects can evolve throughout gestation. Understanding these changes is key for prenatal diagnosis and management of congenital heart disease.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Fetal Medicine

Background:

  • Cardiac embryogenesis is a critical early developmental period (6-7 weeks gestation).
  • Major cardiovascular defects can develop early but also evolve or arise later in gestation.
  • Fetal heart disease encompasses a range of conditions including structural anomalies, valve issues, arrhythmias, and tumors.

Purpose of the Study:

  • To highlight the dynamic nature of fetal heart disease progression.
  • To emphasize the importance of understanding evolving cardiac lesions for management.
  • To underscore the need for knowledge of fetal cardiac development for prognosis and intervention.

Main Methods:

  • Review of established knowledge on fetal cardiac development.
  • Analysis of potential progression pathways for various cardiac lesions.
  • Synthesis of information on the impact of evolving defects on fetal circulation.

Main Results:

  • Cardiovascular defects can develop or progress throughout gestation.
  • Ventricular and great artery hypoplasia, outflow tract obstruction, and valve regurgitation are common evolving issues.
  • Changes in fetal shunts (foramen ovale, ductus arteriosus), arrhythmias, myocardial disease, and tumors can occur.

Conclusions:

  • Knowledge of fetal heart disease progression is crucial for accurate prognosis.
  • Understanding dynamic changes informs prenatal and neonatal management strategies.
  • Comprehensive assessment of evolving fetal cardiac conditions is essential for optimal outcomes.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...